BIOMAT Database Logo BIOMAT Database Logo

[Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)]. 1988

S D Ladefoged, and M Friedberg, and A Glenthøj

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016853 Muromonab-CD3 Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti). Monoclonal Antibody OKT3,OKT3,Orthoclone OKT3,Muromonab CD3

Related Publications

S D Ladefoged, and M Friedberg, and A Glenthøj
[Pentamidine inhalation in prevention of pneumocystis carinii pneumonia in treatment of rejection with monoclonal antibody Orthoclone (OKT-3)].
October 1992, Medizinische Klinik (Munich, Germany : 1983),
S D Ladefoged, and M Friedberg, and A Glenthøj
Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody.
November 1987, Circulation,
S D Ladefoged, and M Friedberg, and A Glenthøj
Nursing care of patients receiving orthoclone OKT 3.
August 1989, ANNA journal,
S D Ladefoged, and M Friedberg, and A Glenthøj
[Use of OKT-3 in treatment of rejection following kidney transplantation].
April 1990, Zeitschrift fur Urologie und Nephrologie,
S D Ladefoged, and M Friedberg, and A Glenthøj
Evolution of renal function during treatment of kidney graft rejection with OKT3 monoclonal antibody.
July 1990, Transplantation,
S D Ladefoged, and M Friedberg, and A Glenthøj
Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients.
August 1992, ANNA journal,
S D Ladefoged, and M Friedberg, and A Glenthøj
Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
April 1987, Transplantation proceedings,
S D Ladefoged, and M Friedberg, and A Glenthøj
Recurrent haemolytic uraemic syndrome in a transplant recipient on orthoclone (OKT 3).
March 1991, Pediatric nephrology (Berlin, Germany),
S D Ladefoged, and M Friedberg, and A Glenthøj
[Immunologic studies of various diseases with monoclonal antibody (OKT 3, 4, 8)].
July 1983, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S D Ladefoged, and M Friedberg, and A Glenthøj
[OKT 3 treatment of kidney transplant recipients].
March 1990, Wiener klinische Wochenschrift,
Copied contents to your clipboard!